In our studies, EZH2 inhibition in HT1376 and T24 bladder cancer cells with KDM6A and/or SWI/SNF family member mutations increased levels of transcripts associated with NK cell activity. The gene discussed is KDM6A; the disease is urinary bladder carcinoma.